Unnatural amino acids are notoriously difficult to synthesize—but AcceleDev has built scalable, cost-effective strategies that outperform traditional approaches. This white paper showcases breakthrough case studies in Strecker synthesis, tyrosine derivative production, and phosphorylated UAA purification. A must-read for any team developing next-generation peptide therapeutics or seeking CDMOs capable of solving the hardest synthetic challenges.